Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

FDA warning: men's testosterone drugs overused
Yahoo/AP
Wed, 03/4/15 - 08:25 am
Tags:
FDA, warnings, testosterone, AbbVie, Eli Lilly, Axiron, Androgel
Salix Suitors May Yet Emerge to Challenge Valeant: Real M&A
Bloomberg
Tue, 02/24/15 - 02:23 pm
Tags:
Salix, Valeant Pharmaceuticals, M&A, Shire, Takeda, AstraZeneca, AbbVie, Actavis, Endo Health Solutions
AbbVie: Amgen Circa 2011?
Barron's
Tue, 02/17/15 - 04:40 pm
Tags:
Amgen, AbbVie
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Tags:
Humira, Sovaldi, Remicade, Enbrel, Lantus, Rituxan, Advair, Avastin, Herceptin, Januvia, Merck, AbbVie, Gilead Sciences, JNJ, Amgen, Pfizer, Sanofi, Roche, GSK
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Motley Fool
Mon, 02/16/15 - 10:19 am
Tags:
Pfizer, Hospira, M&A, Teva Pharmaceutical, AbbVie, Bristol-Myers Squibb, Abbott Labs, Mylan, GSK
Patient groups still think ViiV is tops, with Novo and AbbVie close behind
Fierce Pharma Marketing
Wed, 02/11/15 - 09:47 am
Tags:
ViiV, Novo Nordisk, AbbVie, patients
AbbVie: Big Pharma at a Discount Price
Barron's
Sat, 02/7/15 - 10:47 am
Tags:
AbbVie
Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade
Barron's
Sat, 02/7/15 - 10:23 am
Tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C
No, the Gilead-AbbVie Price War Won’t Derail the Pharmaceutical Rally
Barron's
Thu, 02/5/15 - 04:52 pm
Tags:
Gilead, AbbVie, drug pricing, hepatitis C
Niche Low-T lifestyle clinics might give suffering Lilly, AbbVie meds a boost
Fierce Pharma Marketing
Thu, 02/5/15 - 09:08 am
Tags:
testosterone, Eli Lilly, AbbVie, Axiron, Androgel
AbbVie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%
Seeking Alpha
Mon, 02/2/15 - 03:28 pm
Tags:
AbbVie, hepatitis C, Viekira Pak
Can The Biotech Sector See Stellar Results For 2015 Amid Price Wars?
Bidness Etc.
Mon, 02/2/15 - 09:57 am
Tags:
drug pricing, biotech, Gilead Sciences, AbbVie
AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan
Yahoo
Sat, 01/31/15 - 10:06 am
Tags:
AbbVie, Japan, hepatitis C
Abbvie Expects $3B In Hepatitis C Drug Sales And 40% Of Insured Customers
Forbes
Fri, 01/30/15 - 11:18 am
Tags:
AbbVie, hepatitis C, Viekira Pak
AbbVie shares up 2.6% as company beats profit, sales estimates
Marketwatch
Fri, 01/30/15 - 08:30 am
Tags:
AbbVie, earnings
Gilead Sciences, Inc. Continues To Reign Over The Hepatitis C Market
Bidness Etc.
Fri, 01/30/15 - 08:05 am
Tags:
Gilead Sciences, AbbVie, Harvoni, Sovaldi, hepatitis C, Viekira Pak
Gilead Sciences, Inc. Harvoni Gets Preferred Status From UnitedHealth Group (UNH)
Bidness Etc.
Thu, 01/29/15 - 11:11 am
Tags:
Gilead Sciences, hepatitis C, United Health, Harvoni, AbbVie
Can Gilead Beat AbbVie At Its Own Game?
Seeking Alpha
Thu, 01/29/15 - 07:28 am
Tags:
Gilead, AbbVie, hepatitis C, Harvoni, Sovaldi, Viekira Pak, Express Scripts
AbbVie Hepatitis C Drug Will Be Focus of Profit Report — Earnings Preview
WSJ Online
Tue, 01/27/15 - 04:32 pm
Tags:
AbbVie, earnings, Viekira Pak, hepatitis C
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
Motley Fool
Tue, 01/27/15 - 10:02 am
Tags:
Pfizer, M&A, AstraZeneca, Shire, AbbVie, Isis Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.